These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9560832)

  • 41. [New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
    Sureda A; García Frade LJ; Navarro JL
    Sangre (Barc); 1990 Oct; 35(5):389-96. PubMed ID: 1963241
    [No Abstract]   [Full Text] [Related]  

  • 42. [Low-molecular-weight heparins. The prevention and therapy of thromboembolic diseases].
    Harenberg J; Huhle G; Piazolo L; Malsch R
    Hautarzt; 1997 Nov; 48(11):852-64. PubMed ID: 9518253
    [No Abstract]   [Full Text] [Related]  

  • 43. Pancreatic cancer and thromboembolic disease.
    Khorana AA; Fine RL
    Lancet Oncol; 2004 Nov; 5(11):655-63. PubMed ID: 15522652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in the prevention of venous thromboembolic disease in orthopaedics: the introduction of LMWH.
    Colwell CW; Paiement G; Pellegrini VD; Salvati EA; Stulberg BN
    Contemp Orthop; 1993 Dec; 27(6):551-77. PubMed ID: 10146586
    [No Abstract]   [Full Text] [Related]  

  • 45. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
    Meurin P; Tabet JY
    Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
    [No Abstract]   [Full Text] [Related]  

  • 46. Coagulation, anticoagulation and pancreatic carcinoma.
    Nakchbandi IA; Löhr JM
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):445-55. PubMed ID: 18594494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Managing the risk of venous thromboembolism in orthopedics: concluding remarks.
    Haas S
    Orthopedics; 1997 Feb; 20 Suppl():26-7. PubMed ID: 9048405
    [No Abstract]   [Full Text] [Related]  

  • 48. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
    Lee AY; Rickles FR; Julian JA; Gent M; Baker RI; Bowden C; Kakkar AK; Prins M; Levine MN
    J Clin Oncol; 2005 Apr; 23(10):2123-9. PubMed ID: 15699480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
    MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
    [No Abstract]   [Full Text] [Related]  

  • 51. [Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics].
    Nikolov A; Kovachev I; Petkov Iu; Dimitrov A
    Akush Ginekol (Sofiia); 2000; 39(3):35-40. PubMed ID: 11187995
    [No Abstract]   [Full Text] [Related]  

  • 52. Low-molecular-weight heparins: a new generation of anticoagulants.
    Messerschmidt K
    S D J Med; 1998 Feb; 51(2):47-8. PubMed ID: 9509889
    [No Abstract]   [Full Text] [Related]  

  • 53. Randomised evaluation of treatment modalities in thromboembolic disorders.
    ten Cate JW; Büller HR
    Haematologica; 1999 Jun; 84 Suppl EHA-4():85-7. PubMed ID: 10907478
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preventive and therapeutic anticoagulation in theory and practice: updates in thrombosis prevention].
    Wilke S
    Pflege Z; 2009 Jul; 62(7):412-5. PubMed ID: 19634523
    [No Abstract]   [Full Text] [Related]  

  • 56. Ensuring safety of biosimilar low-molecular-weight heparins: a consensus statement of the International Union of Angiology .
    Harenberg J; Kalodiki E; Walenga JM;
    Int Angiol; 2012 Apr; 31(2):101-4. PubMed ID: 22466973
    [No Abstract]   [Full Text] [Related]  

  • 57. [The risk of venous thromboembolism during air travel].
    Sanchez O
    Rev Prat; 2007 Apr; 57(7):721-3. PubMed ID: 17654820
    [No Abstract]   [Full Text] [Related]  

  • 58. Deep vein thromboembolism in malignant diseases.
    Zemková M; Meyboom RH; Blazek M; Kotlárová J; Vlcek J; Jebavý L
    Ceska Slov Farm; 2007 Jan; 56(1):5-10. PubMed ID: 17432275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism?
    Sharma GK
    Arch Intern Med; 2000 Jul; 160(13):2065-6. PubMed ID: 10888989
    [No Abstract]   [Full Text] [Related]  

  • 60. Managing the risk of venous thromboembolism in orthopedics: introductory remarks.
    Fitzgerald RH
    Orthopedics; 1997 Feb; 20 Suppl():6. PubMed ID: 9048399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.